Você procurou por: metaflumitsoni (Finlandês - Inglês)

metaflumitsoni
metaflumizone

metaflumitsoni (mg)
metaflumizone (mg)

promeris metaflumitsoni
promeris metaflumizone

promeris duo metaflumitsoni ja amitratsi
promeris duo metaflumizone and amitraz

metaflumitsoni 999 mg ja amitratsi 999 mg
metaflumizone 999 mg and amitraz 999 mg

metaflumitsoni (e- ja z-isomeerien summa)
metaflumizone (sum of e- and z- isomers)

metaflumitsoni on ulkoloismyrkky, joka kuuluu semikarbatsoniryhmän yhdisteisiin.
metaflumizone is an ectoparasiticide belonging to the semicarbazone group of compounds.

metaflumitsoni tehoaa kirppuihin paikallisesti iholla ja karvassa.
metaflumizone is active against fleas due to non-systemic exposure of the parasites on the skin and hair.

metaflumitsoni (iso) (cas rn 139968-49-3)
metaflumizone (iso) (cas rn 139968-49-3)

metaflumitsoni oli mitattavissa karvasta vielä 56 päivää hoidon jälkeen.
metaflumizone was still measurable in the hair 56 days following treatment.

metaflumitsoni on natriumkanava-antagonisti ja häiritsee hermojen toimintaa aiheuttamalla hyönteisen paralyysin ja kuoleman.
metaflumizone is a sodium channel antagonist and disrupts nerve function resulting in paralysis and death of insects.

yksittäiseen kohtaan kissan niskaan kallon tyveen annetun paikallisannoksen jälkeen metaflumitsoni jakautuu nopeasti ihon pinnan läpi.
after topical administration at a single site on the cat’s neck at the base of the skull, metaflumizone is rapidly distributed throughout the surface of the skin.

promeris-valmisteen vaikuttava aine metaflumitsoni vaikuttaa kirppujen hermotoimintaan ja johtaa siten näiden loisten kuolemaan.
data were provided on the pharmaceutical quality, the safety of the product in cats and the safety in humans (people in contact with the product) and the environment.the effectiveness of metaflumizone against flea infestations in cats was investigated in laboratory studies and in a field trial.

yksittäiseen kohtaan kallon tyveen annetun paikallisannoksen jälkeen sekä metaflumitsoni- että amitratsiarvot plasmassa olivat liian alhaisia tavallisten farmakokineettisten parametrien määritykseen.
after topical administration at a single site at the base of the skull, both metaflumizone and amitraz levels in plasma were too low to allow the calculation of standard pharmacokinetic parameters.

promeris duo -valmisteen molemmat vaikuttavat aineet, metaflumitsoni ja amitratsi, vaikuttavat loisten hermotoimintaan ja johtavat siten näiden loisten kuolemaan.
both active substances in promeris duo, metaflumizone and amitraz, interfere with the neural activity of the parasites and consequently lead to their death.

100, 5 mg metaflumitsoni ja 100, 5 mg amitratsi 100, 5 mg metaflumitsoni ja 100, 5 mg amitratsi 199, 5 mg metaflumitsoni ja 199, 5 mg amitratsi 199, 5 mg metaflumitsoni ja 199, 5 mg amitratsi 499, 5 mg metaflumitsoni ja 499, 5 mg amitratsi 499, 5 mg metaflumitsoni ja 499, 5 mg amitratsi 799, 5 mg metaflumitsoni ja 799, 5 mg amitratsi 799, 5 mg metaflumitsoni ja 799, 5 mg amitratsi 999 mg metaflumitsoni ja 999 mg amitratsi 999 mg metaflumitsoni ja 999 mg amitratsi
100.5 mg metaflumizone and 100.5 mg amitraz 100.5 mg metaflumizone and 100.5 mg amitraz 199.5 mg metaflumizone and 199.5 mg amitraz 199.5 mg metaflumizone and 199.5 mg amitraz 499.5 mg metaflumizone and 499.5 mg amitraz 499.5 mg metaflumizone and 499.5 mg amitraz 799.5 mg metaflumizone and 799.5 mg amitraz 799.5 mg metaflumizone and 799.5 mg amitraz 999 mg metaflumizone and 999 mg amitraz 999 mg metaflumizone and 999 mg amitraz